Cyclooxygenases

Cyclooxygenase (also known as COX, Prostaglandin-endoperoxide synthase, Prostaglandin G/H synthase) is expressed in cells in three isoforms. COX-1 (constitutive) and COX-2 (inducible) isoforms catalyze the rate-limiting step of prostaglandin production.

Products
Background
Literature
Gene Data

Inhibitors

Cat No Product Name / Activity
1706 Acetaminophen
Cyclooxygenase inhibitor; may be selective for COX-3
4092 Aspirin
Cyclooxygenase inhibitor; NSAID
3786 Celecoxib
Selective cyclooxygenase-2 (COX-2) inhibitor
4454 Diclofenac sodium salt
Cyclooxygenase inhibitor; NSAID
1430 DuP 697
Cyclooxygenase-2 (COX-2) inhibitor
3871 Etodolac
Selective cyclooxygenase-2 (COX-2) inhibitor; NSAID
2776 FK 3311
Cyclooxygenase-2 (COX-2) inhibitor
4522 Flufenamic acid
Cyclooxygenase inhibitor; NSAID. Also activates TRPC6
1769 Flurbiprofen
Cyclooxygenase inhibitor
1507 FR 122047 hydrochloride
Cyclooxygenase (COX-1) inhibitor
2796 (S)-(+)-Ibuprofen
Cyclooxygenase inhibitor (COX-1 > COX-2)
1708 Indomethacin
Cyclooxygenase inhibitor (COX-1 > COX-2)
2655 Naproxen sodium
Cyclooxygenase inhibitor
4531 NCX 4040
NO-donating aspirin; anti-inflammatory and antitumor
4537 NCX 466
Cyclooxygenase-inhibiting nitric oxide donor
4112 Niflumic acid
Cyclooxygenase-2 (COX-2) inhibitor; GPR35 agonist
2470 Nimesulide
Cyclooxygenase-2 (COX-2) inhibitor
0942 NS 398
Cyclooxygenase-2 (COX-2) inhibitor
0960 Piroxicam
Cyclooxygenase-1 (COX-1) inhibitor
1418 Resveratrol
Cyclooxygenase inhibitor
1550 SC 560
Cyclooxygenase-1 (COX-1) inhibitor
2895 SC 58125
Selective cyclooxygenase-2 (COX-2) inhibitor
3919 SC 236
Selective cyclooxygenase-2 (COX-2) inhibitor
1707 Sulindac
Cyclooxygenase inhibitor (following metabolism to sulindac sulfide)
2510 Talniflumate
Cyclooxygenase inhibitor. Also chloride channel blocker
2580 Tenidap
NSAID, cyclooxygenase (COX-1) inhibitor. Also opener of KIR2.3
4206 Valdecoxib
Selective and potent COX-2 inhibitor

Related Targets

    Cyclooxygenase (also known as COX, Prostaglandin-endoperoxide synthase, Prostaglandin G/H synthase) is expressed in cells in three isoforms: COX-1, COX-2 and COX-3. COX-1 (constitutive) and COX-2 (inducible) isoforms catalyze the rate-limiting step of prostaglandin production and are the targets of non-steroidal anti-inflammatory drugs. COX-3 does not appear to be involved in inflammatory processes, but seems to be involved in pain and fever. COX-3 is thought to be derived through the retention of the highly structured G + C-rich intron 1 of the COX-1 gene.

    Literature for Cyclooxygenases

    Cancer

    Cancer Research Product Guide

    A collection of over 750 products for cancer research, the guide includes research tools for the study of:

    • Cancer Metabolism
    • Epigenetics in Cancer
    • Receptor Signaling
    • Cell Cycle and DNA Damage Repair
    • Angiogenesis
    • Invasion and Metastasis
    Immunology

    Immunology Product Listing

    A collection of over 190 products for immunology research, the guide includes research tools for the study of:

    • Chemokine and Cytokine Signaling
    • Chemotaxis
    • Complement System
    • Immune Cell Signaling
    • Inflammation
    Pain

    Pain Research Product Guide

    A collection of over 250 products for pain research, the guide includes research tools for the study of:

    • Nociception
    • Ion Channels
    • G-Protein-Coupled Receptors
    • Intracellular Signaling
    Alzheimer's

    Alzheimer's Poster

    Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.

    Asthma

    Asthma Poster

    Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.

    Parkinson's

    Parkinson's Poster

    Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.

    Cyclooxygenase Gene Data

    Gene Species Gene Symbol Gene Accession No. Protein Accession No.
    COX-1 Human PTGS1 NM_000962 P23219
    Mouse Ptgs1 NM_008969 P22437
    Rat Ptgs1 NM_017043 Q63921
    COX-2 Human PTGS2 NM_000963 P35354
    Mouse Ptgs2 NM_011198 Q05769
    Rat Ptgs2 NM_017232 P35355